ALK and neoplasm: DNA nanomicelles loaded with doxorubicine and ALK-specific siRNA induced apoptosis of ALCL K299 cells in vitro and inhibited tumor growth in vivo, potentially representing another therapeutical approach to treat these tumors [337].